1. Management of multiple myeloma today;Anderson;Seminars in Hematology,1999
2. Thalidomide is an inhibitor of angiogenesis;D'amato;Proceedings of the National Academy of Sciences USA,1994
3. Clinical applications of research on angiogenesis;Folkman;New England Journal of Medicine,1995
4. Angiogenesis in newly diagnosed multiple myeloma: poor prognosis with increased microvessel density in bone marrow biopsies;Munshi;Blood,1998
5. Marked anti-tumor effect from anti-angiogenesis therapy with thalidomide in high risk refractory multiple myeloma;Singhal;Blood,1998